BI Asset Management Fondsmaeglerselskab A S Has $21.67 Million Holdings in Tenet Healthcare Co. (NYSE:THC)

BI Asset Management Fondsmaeglerselskab A S grew its holdings in Tenet Healthcare Co. (NYSE:THC - Free Report) by 41.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 171,676 shares of the company's stock after purchasing an additional 50,421 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S owned about 0.18% of Tenet Healthcare worth $21,671,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in THC. GeoWealth Management LLC boosted its holdings in Tenet Healthcare by 39.8% in the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company's stock valued at $37,000 after purchasing an additional 84 shares during the period. WR Wealth Planners LLC lifted its stake in shares of Tenet Healthcare by 2,836.4% in the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company's stock valued at $41,000 after buying an additional 312 shares during the period. Smartleaf Asset Management LLC increased its stake in Tenet Healthcare by 30.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 471 shares of the company's stock valued at $59,000 after acquiring an additional 110 shares during the period. Kestra Investment Management LLC bought a new stake in shares of Tenet Healthcare in the 4th quarter worth approximately $60,000. Finally, Wilmington Savings Fund Society FSB grew its holdings in shares of Tenet Healthcare by 1,352.8% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company's stock worth $66,000 after purchasing an additional 487 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company's stock.

Analysts Set New Price Targets

THC has been the topic of a number of recent research reports. TD Cowen began coverage on shares of Tenet Healthcare in a research note on Wednesday, February 26th. They set a "buy" rating and a $175.00 price target on the stock. Guggenheim initiated coverage on Tenet Healthcare in a report on Wednesday, April 9th. They set a "buy" rating and a $165.00 price objective on the stock. StockNews.com raised Tenet Healthcare from a "hold" rating to a "buy" rating in a report on Thursday, March 13th. Morgan Stanley started coverage on Tenet Healthcare in a research report on Wednesday, March 26th. They issued an "overweight" rating and a $165.00 price target on the stock. Finally, Truist Financial cut their price objective on Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating for the company in a report on Monday, January 6th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $165.44.

Tenet Healthcare Trading Up 3.3 %

Shares of NYSE THC traded up $3.98 during midday trading on Thursday, hitting $125.03. The stock had a trading volume of 502,800 shares, compared to its average volume of 1,509,578. The company's 50-day simple moving average is $126.95 and its 200 day simple moving average is $137.42. The firm has a market cap of $11.80 billion, a P/E ratio of 3.88, a price-to-earnings-growth ratio of 1.02 and a beta of 1.77. Tenet Healthcare Co. has a fifty-two week low of $92.01 and a fifty-two week high of $171.20. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. Research analysts anticipate that Tenet Healthcare Co. will post 12.24 EPS for the current year.

Insider Buying and Selling

In other news, Director J Robert Kerrey sold 9,525 shares of the business's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the transaction, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.93% of the stock is owned by insiders.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.